rMark Bio, Inc. — Form D/A
rMark Bio, Inc. of Chicago, IL, a company, filed a Form D amendment with the SEC on 2020-10-14. The offering totals $4.0M, of which $2.8M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-10-14
- Form: D/A
- Accession: 0000898432-20-000813
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $2.8M
- Remaining: $1.2M
- Investors: 8
- Date of first sale: 2019-10-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-351136
Issuer
- Name: rMark Bio, Inc.
- CIK: 0001730006
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 222 W. Merchandise Mart Plaza, Chicago, IL, 60654
- Phone: (425) 503-5044
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Mark Achler | Director | Chicago, IL |
| John Clyman | Director | Chicago, IL |
| Jason Smith | Director | EXTON, PA |
| Jason Smith | Executive Officer | EXTON, PA |
| Mark Achier | Director | CHICAGO, IL |
| Lev Becker | Director | Chicago, IL |
| Lev Becker | Executive Officer | Chicago, IL |
Other filings by this issuer (3)
More